Inactief instrument

Andere talen POIT BIOP

Aandelen

RACA

US7305411099

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

POINT Biopharma Global Inc.(NasdaqCM:PNT) dropped from S&P Biotechnology Select Industry Index	29/12
POINT Biopharma Global Inc.(NasdaqCM:PNT) dropped from S&P Global BMI Index	29/12
POINT Biopharma Global Inc.(NasdaqCM:PNT) dropped from S&P TMI Index	29/12
Fusion Pharmaceuticals an 'Attractive' Takeover Target Following Recent Radiopharma Deals, Oppenheimer Says	27/12
Fusion Pharmaceuticals 'Last Available Target' With Solid Supply Chain After Point Biopharma, RayzeBio Takeovers, Oppenheimer Says	27/12
Swiss Shares Decline Amid Lingering Concerns for Growth of Local Economy	27/12
Eli Lilly : succès de l'OPA sur POINT Biopharma Global	27/12
Williams : Eli Lilly, Williams Cos...les valeurs à suivre aujourd'hui à Wall Street	27/12
Eli Lilly Completes Acquisition of Point Biopharma Global	27/12
Eli Lilly Completes Acquisition of POINT Biopharma Global	27/12
Lilly Completes Acquisition of POINT Biopharma	27/12
Eli Lilly Closes $1.4 Billion Takeover of Point Biopharma	27/12
Eli Lilly and : finalise le rachat de Point Biopharma	27/12
POINT Biopharma Global Inc.(NasdaqCM:PNT) dropped from NASDAQ Composite Index	27/12
Eli Lilly and Company completed the acquisition of POINT Biopharma Global Inc. from Joe A. McCann, Allan Charles Silber, Neil E. Fleshner and others.	27/12
North American Morning Briefing : Dow Futures Fall -2-	22/12
Lantheus, POINT Biopharma Say Trial of 177Lu-PNT2002 for Metastatic Castration-Resistant Prostate Cancer Meets Endpoint	18/12
Eli Lilly Extends Tender Offer for POINT Biopharma Acquisition to Dec. 22	18/12
Eli Lilly : prolonge encore l'OPA sur Point Biopharma Global	18/12
Lantheus Holdings, Inc. and POINT Biopharma Global Inc. Announce Positive Topline Results from Pivotal Splash Trial in Metastatic Castration-Resistant Prostate Cancer	18/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen POIT BIOP

Aandelen

RACA

US7305411099

Andere talen

Filters